
    
      This is prospective, randomized, single-blind, controlled, single center study. The total
      study duration for each patient should be 12 +/- 1 month.

      In total 13 visits per patient are scheduled in this study.

      The study devices Straumann Bone Ceramic and Bio-Oss are CE-marked, and approved by the FDA.
      The products are used within the indication.

      One center in the Inited Kingdom will participate.
    
  